Economics Can Help Tackle the Global Challenge of Antimicrobial Resistance
Recent reports commissioned by the UK government estimate that if no action is taken, by 2050 AMR will cause up to 10 million annual deaths globally. The substantial effect on the health and productivity of the workforce may also reduce gross domestic product (GDP) by 2 to 3.5%. A review published in Science argues that a range of economic levers can help tackle the challenges AMR presents, including assessing the full social cost of antibiotic use when the impact of resistance levels on health and GDP are taken into account.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.